|
|
 |
|
Viewing report
|
|
|
|
ExecSense Online Conference: Exit Strategy Options for Chemical Companies in 2011-2012
ExecSense, May 2011, Pages: 180
In Exit Strategy Options for Chemical Companies in 2011-2012, the analyst examines what CEOs, CFOs (and their management teams) need to know about why the next year is a good time to consider selling their company to a strategic partner, competitor, or private equity fund, as analysts are expecting over 300 M&A deals in 2011 alone. Take the time to view this online conference from the comfort of your office (on your computer, mobile phone, iPad, or printed out) to make sure you fully understand who is making acquisitions, current deal terms, how to increase your valuation and why many industry experts are saying the next 24 months could be one of the best times in the near future to consider selling your chemical company.
Upon registering, we will email you the call-in number for you to listen from your office or mobile phone while viewing the PowerPoint slides (while you can view the online conference online, we will also be emailing you the PowerPoint and audio files so you can listen offline, print out the slides, or even transfer the slide jpegs to view on your Blackberry/iPhone/iPod/iPad/Kindle).
This online conference features the insights of a panel of investment bankers, industry analysts and lawyers that all have extensive experience specifically working with chemical companies, including Steven M. Cohen, Partner, Morgan, Lewis & Bockius LLP, Allan M. Benton, Vice Chairman, Group Head- Chemicals, Scott-Macon & John A. Mascarich, VP, Senior Investment Banker, Hilliard Lyons Investment Banking and focuses on:
- Everything you need to know about the best exit strategy options for chemical companies in 2011-2012
- Insight into recent deals in the chemical sector and how you can capitalize on the industry's current push towards improving operating efficiencies through mergers and acquisitions
- Perspectives from leading chemical investment bankers on why the next 24 months may be a very good time to consider selling your chemical company
- A list of the chemical companies & private equity firms that are most actively doing acquisitions right now, what types of companies they are buying, important deal points to note about their most recent acquisitions, and how to best position your company to create a bidding type atmosphere to get you the highest valuation possible
- Alternative options to selling your entire company, including selling a minority or majority stake in the company due to favorable tax laws for 2012, estate planning opportunities, and the current state and volatility of the financial markets
- A comprehensive overview of being acquired versus a merger, reverse-merger, IPO, and other potential exit strategies, including a detailed look at the financial and legal sides of each strategy and how they would impact management, employees, and investors/shareholders
- How to identify and approach a strategic partner, competitor, or private equity fund that is the optimal fit for acquiring your company
- The 10 questions most frequently asked by CEOs and CFOs of chemical companies about what factors impact their company's valuation and attractiveness to buyers (or public investors), and what they should be doing right now to best position their company for a successful exit strategy
- Case studies of other chemical companies that have recently sold in the current economic environment, what had the greatest impact on getting them the best deal terms and valuation possible, and key lessons for positioning your own company for a successful exit strategy
- This online conference also includes a 15-page research report featuring comparable analysis of acquisitions in the chemical industry, the most up-to-date information on chemical company valuations, acquisition deal terms, negotiation strategies, tax strategies, and more, including a detailed look at the financial and legal sides of key deal terms and how they would impact the CEO, management, employees, and investors/shareholders
These online conferences have been attended by CEOs in over 22 countries, C-Level executives from over 3,200 private companies, and C-Level executives from the world's top public companies such as Johnson & Johnson, Oracle, Siemens, Amazon.com, Accenture, HP, Kraft, UPS, Nike, Mayo Clinic, Wells Fargo, Visa, Humana, Whole Foods, Intel, and Standard & Poors.
Praise for ExecSense Webinars & Online Conferences:
'Dynamic, up-to-date resource...' - Tina Ferguson, CEO of Rapid Success Partners
'Well organized, well articulated, and easy to follow...the best virtual learning experience I've had in quite some time.' - Brian K. Moore, HR Communications, Humana
'Concise and to-the-point information presented by experts in the subject matter...' - John Johnson, Partner, Christian & Small
'...convenient and on-point...an intelligent discussion on a very relevant subject.' - Meghan Wulff, Focus Management Group
'An expeditious way to obtain authoritative current information and ideas...' - David Kera, Partner, Oblon Spivak
|
|
|
|
